Two Sigma Advisers’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,700
Closed -$865K 1567
2025
Q4
$865K Buy
33,700
+9,900
+42% +$228K ﹤0.01% 1557
2025
Q3
$512K Buy
23,800
+500
+2% +$11.4K ﹤0.01% 1757
2025
Q2
$513K Sell
23,300
-4,800
-17% -$105K ﹤0.01% 1740
2025
Q1
$628K Sell
28,100
-238,000
-89% -$5.13M ﹤0.01% 1683
2024
Q4
$4.59M Buy
266,100
+121,300
+84% +$1.88M 0.01% 748
2024
Q3
$2.43M Buy
+144,800
New +$3.48M 0.01% 977
2023
Q3
Sell
-170,700
Closed -$6.72M 2531
2023
Q2
$6.72M Sell
170,700
-31,500
-16% -$1.14M 0.02% 635
2023
Q1
$6.49M Buy
202,200
+78,200
+63% +$2.58M 0.02% 706
2022
Q4
$3.86M Buy
124,000
+12,400
+11% +$448K 0.01% 884
2022
Q3
$4.14M Buy
111,600
+90,100
+419% +$3.37M 0.01% 830
2022
Q2
$625K Buy
+21,500
New +$770K ﹤0.01% 1825
2021
Q3
Sell
-11,600
Closed -$684K 2629
2021
Q2
$684K Buy
+11,600
New +$652K ﹤0.01% 1801
2020
Q4
Sell
-16,200
Closed -$477K 2536
2020
Q3
$477K Sell
16,200
-6,000
-27% -$165K ﹤0.01% 1845
2020
Q2
$573K Buy
22,200
+7,900
+55% +$181K ﹤0.01% 1831
2020
Q1
$303K Sell
14,300
-8,000
-36% -$220K ﹤0.01% 2008
2019
Q4
$612K Buy
+22,300
New +$535K ﹤0.01% 1785

Other funds holding PGNY

Two Sigma Advisers's PGNY Position: Q1 2026 in Review

Two Sigma Advisers sold out of Progyny (PGNY) in Q1 2026, closing a stake of 33,700 shares — an estimated $865K sold.

Two Sigma Advisers first reported a position in PGNY in Q4 2019 and held it in 16 quarters. The position peaked at $6.72M in Q2 2023. 291 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • Two Sigma Advisers reported no remaining Progyny position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 33,700 Progyny shares in Q1 2026, an estimated $865K.
  • Two Sigma Advisers first reported a position in Progyny in Q4 2019 and held it in 16 quarters.
  • Two Sigma Advisers's Progyny position peaked at $6.72M in Q2 2023.
  • 291 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.